GENEDX HOLDINGS (WGS)
(Delayed Data from NSDQ)
$121.37 USD
-0.67 (-0.55%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $122.25 +0.88 (0.73%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth C Momentum C VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
WGS 121.37 -0.67(-0.55%)
Will WGS be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for WGS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for WGS
Here's Why Ensign Group Shares Are Attracting Investors Now
Here's Why Pediatrix Medical Shares Are Attracting Investors Now
WGS: What are Zacks experts saying now?
Zacks Private Portfolio Services
PAHC Stock Surges on Q4 Earnings & Revenue Beat, Gross Margin Down
Alcon's Q2 Earnings Beat Estimates, Revenues Miss, Stock Plunges
MDT Stock Falls Despite Q1 Earnings & Revenue Beat, FY26 EPS View Up
Other News for WGS
Is WGS set to breakout? NR7 shows up after sliding 1.54%
NR7 appears for WGS after 1.54% move
20 Day Moving Average Resistance appears for WGS after 2.19% move
Piper Sandler Raises Price Target for GeneDx Holdings (WGS) to $140 | WGS Stock News
WGS Fell Below 20 Day Moving Average on September 10